RUBICON GENOMICS INC / TAKARA BIO INC / Acquisition / Private / £59m

Synopsis

Acquisition by Takara Bio USA Holdings, Inc., a wholly owned subsidiary of Takara Bio, Inc. and a leading global biotechnology and life science company, of Rubicon Genomics, Inc., a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency and speed of genomic analysis.

Principals

target

Rubicon Genomics

bidder

Takara Bio

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy